Official UK procurement notice
Egg-based Quadrivalent Influenza Vaccine
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)
What is being bought
Published requirement descriptionThis procurement is for the supply of egg-based quadrivalent influenza vaccine, suitable for use from age 6 months, to NHSScotland for use in the annual seasonal influenza immunisation programme.
CPV: Influenza vaccines
The lotProcurement structure
single lot · no lot value publishedLot #1This procurement is for the supply of egg-based quadrivalent influenza vaccine,…Awarded
This procurement is for the supply of egg-based quadrivalent influenza vaccine, suitable for use from age 6 months, for use in the annual seasonal influenza immunisation programme.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 9 Apr 2021, 13:15 BST
- Last source update
- 29 Apr 2021, 17:04 BST
- Authority reference
NP93821c- FTS notice number
2021/S 000-009339- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02a44fFind a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
Aventis Pharma t/a Sanofi are currently the only supplier with egg-based quadrivalent influenza vaccine licenced for use in the UK from age 6 months.
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts(Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
Publisher note: The estimated values referred to in section II.I.7 and V.2.4 covers the full twelve (12) month duration of the contract. (SC Ref:651032)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Aventis Pharma Ltd Trading As Sanofi | £5,000 †same award published again · counted once | — | Awarded |
| Aventis Pharma Ltd Trading As Sanofi | £5,000 † | — | Awarded |
Contracts
Contract 007390-2021-NP93821c-1 · Aventis Pharma Ltd Trading As Sanofi
- Signed
- 9 Apr 2021
- Value
- £5,000
- Status
- active
Contract 009339-2021-NP93821c-1 · Aventis Pharma Ltd Trading As Sanofi
- Signed
- 9 Apr 2021
- Value
- £5,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic · 1 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sherriff Court HouseReview body
Bidders & participating suppliers
1 commercial party on the notice- Aventis Pharma Ltd t/a SanofiAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.